Novartis' Sandoz: Between Generics and Pharma
Saved in:
| Title: | Novartis' Sandoz: Between Generics and Pharma |
|---|---|
| Description: | Sandoz, which made a significant investment in bio-similars as a way to differentiate itself from its generic drug industry peers, has to negotiate with its parent company and the innovative pharma division on how best to commercialize its bio-similar portfolio. What is the best way to balance the parenting advantage of Novartis with the unique demands of the generic drug industry? |
| Authors: | Carin-Isabel Knoop, Krishna G. Palepu |
| Resource Type: | eBook. |
| Categories: | BUSINESS & ECONOMICS / General |
| Database: | eBook Collection (EBSCOhost) |
Be the first to leave a comment!
